Patents by Inventor Elizabeth Doolin

Elizabeth Doolin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC FORMULATIONS AND USES THEREOF
    Publication number: 20230147869
    Abstract: This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the ?7-nicotinic receptor with non-sedative anxiolytic effects; specifically, solid dispersions, methods of manufacture thereof, and therapeutic methods and uses in the treatment of diseases of the central nervous system thereof.
    Type: Application
    Filed: February 17, 2020
    Publication date: May 11, 2023
    Inventors: Dharam Paul, Julia Crossman, Elizabeth Doolin, Tom Reynolds, Xiangming Wu, Jeff Millan, Thomas Stumpfig, Kristie Downing
  • Method of treating cancer by administering an anti-LGR5 monoclonal antibody
    Patent number: 10745487
    Abstract: The present invention relates generally to the field of cancer biology. Some embodiments of the methods and compositions provided herein relate to administration of humanized antibodies or antigen-binding fragments thereof that specifically bind to LRG5 to treat certain cancers.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: August 18, 2020
    Assignee: BIONOMICS LIMITED
    Inventors: Christopher L. Reyes, Peter Chu, Elizabeth Doolin, Jose Iglesias
  • ADMINISTRATION OF AN ANTI-LGR5 MONOCLONAL ANTIBODY
    Publication number: 20190100600
    Abstract: The present invention relates generally to the field of cancer biology.
    Type: Application
    Filed: March 21, 2017
    Publication date: April 4, 2019
    Inventors: Christopher L. Reyes, Peter Chu, Elizabeth Doolin, Jose Iglesias